Indivior Pharmaceuticals (INDV) Net Equity Issued and Repurchased (2024 - 2025)
Indivior Pharmaceuticals (INDV) posted quarterly Net Equity Issued and Repurchased of $1.0 million for Q3 2025, little changed year-over-year from $1.0 million in Q3 2024, and little changed quarter-over-quarter from $1.0 million in Q1 2025.
Indivior Pharmaceuticals (INDV) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Indivior Pharmaceuticals' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2025.
- In Q3 2025, Net Equity Issued and Repurchased changed 0.0% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 50.0% YoY), while the FY2025 annual figure was $2.0 million, down 33.33% from the prior year.
- Net Equity Issued and Repurchased for Q3 2025 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $2.0 million in Q1 2024, with the low at $1.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |